$SSII
SS Innovations International, Inc. Stock $ssii

$ssii Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023064089 Filed on August 07, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$1.430M	$1.575M	$0.00
YoY Change
Cost Of Revenue	$1.270M	$1.351M	$315.7K
YoY Change	75.17%	1930.88%	134.12%
Gross Profit	$159.8K	$224.2K	-$315.7K
YoY Change	-122.05%	-436.94%	134.12%
Gross Profit Margin	11.18%	14.23%
Selling, General & Admin	$1.275M	$1.983M	$908.3K
YoY Change	627.86%	1815.99%	541.8%
% of Gross Profit	797.69%	884.64%
Research & Development	$293.1K		$72.96K
YoY Change
% of Gross Profit	183.36%
Depreciation & Amortization	-$83.68K	$308.6K	$2.280K
YoY Change	-3786.34%	13435.96%	-23.49%
% of Gross Profit	-52.35%	137.68%
Operating Expenses	$2.132M	$1.983M	$981.2K
YoY Change	136.88%	1066.3%	593.41%
Operating Profit	-$1.972M	-$1.759M	-$1.297M
YoY Change	21.37%	643.53%	369.29%
Interest Expense	-$11.48K	-$91.53K	-$45.49K
YoY Change	-28800.0%		-151733.33%
% of Operating Profit
Other Income/Expense, Net	-$11.48K	-$91.53K	$170.0K
YoY Change	-110.43%	-315731.03%	-319.64%
Pretax Income	-$1.984M	-$1.850M	-$1.172M
YoY Change	151.1%	988.48%	231.46%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$1.984M	-$1.850M	-$1.172M
YoY Change	151.1%	988.48%	231.46%
Net Earnings / Revenue	-138.76%	-117.46%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	146.2M shares	146.2M shares	39.20M shares
Diluted Shares Outstanding	146.7M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.596M	$423.1K	$1.351M
YoY Change	1182.96%	62.04%	233.04%
Cash & Equivalents	$6.596M	$423.1K	$1.351M
Short-Term Investments
Other Short-Term Assets	$7.049M	$1.383M	$8.680K
YoY Change	33337.24%	60309.17%	279.04%
Inventory	$4.171M	$2.608M
Prepaid Expenses
Receivables	$1.512M	$1.070M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$19.33M	$5.485M	$4.360M
YoY Change	1081.98%	1982.66%	968.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$661.6K	$436.5K	$11.40K
YoY Change	4736.83%	2635.53%	-44.51%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$4.731M	$4.208M	$11.40K
YoY Change	34488.14%	26271.21%	-44.51%
TOTAL ASSETS
Total Short-Term Assets	$19.33M	$5.485M	$4.360M
Total Long-Term Assets	$4.731M	$4.208M	$11.40K
Total Assets	$24.06M	$9.693M	$4.371M
YoY Change	1359.09%	3370.13%	919.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$175.8K	$31.76K
YoY Change	168.06%	-43.17%
Accrued Expenses	$1.996M	$2.131M	$5.700K
YoY Change	34912.63%	10193.86%	-67.8%
Deferred Revenue
YoY Change
Short-Term Debt	$6.118M	$6.188M	$4.000M
YoY Change	456.2%
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$8.296M	$8.372M	$4.051M
YoY Change	530.28%	3678.11%	1310.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$500.0K	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$500.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.296M	$8.372M	$4.051M
Total Long-Term Liabilities	$0.00	$500.0K	$0.00
Total Liabilities	$8.296M	$8.872M	$4.051M
YoY Change	530.28%	3903.85%	1310.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.09M	-$19.10M	-$10.69M
YoY Change	121.52%	118.85%	26.1%
Common Stock	$36.21M	$14.62K	$5.389K
YoY Change	886780.87%	283.7%	42.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.76M	$821.6K	$320.2K
YoY Change
Total Liabilities & Shareholders Equity	$24.06M	$9.693M	$4.371M
YoY Change	1359.09%	3370.13%	919.92%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.984M	-$1.850M	-$1.172M
YoY Change	151.1%	988.48%	231.46%
Depreciation, Depletion And Amortization	-$83.68K	$308.6K	$2.280K
YoY Change	-3786.34%	13435.96%	-23.49%
Cash From Operating Activities	-$3.152M	-$10.34M	-$1.132M
YoY Change	3525.41%	6451.67%	887.72%
INVESTING ACTIVITIES
Capital Expenditures	$141.4K	$736.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$3.298M	$1.228M	-$1.900M
YoY Change	199.8%		-7407.69%
Cash From Investing Activities	-$3.439M	$492.5K	-$1.900M
YoY Change	212.66%		-7407.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.76M	9.825M	3.869M
YoY Change	786.41%	13530.04%	1237.95%
NET CHANGE
Cash From Operating Activities	-3.152M	-10.34M	-1.132M
Cash From Investing Activities	-3.439M	492.5K	-1.900M
Cash From Financing Activities	12.76M	9.825M	3.869M
Net Change In Cash	6.173M	-25.49K	837.2K
YoY Change	2339.41%	-70.28%	317.4%
FREE CASH FLOW
Cash From Operating Activities	-$3.152M	-$10.34M	-$1.132M
Capital Expenditures	$141.4K	$736.0K
Free Cash Flow	-$3.293M	-$11.08M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-216054
	dei	Entity Registrant Name EntityRegistrantName	SS INNOVATIONS INTERNATIONAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3478854
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1500 SE 15th Street,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	#512,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Fort Lauderdale,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33316
	dei	City Area Code CityAreaCode	(954)
	dei	Local Phone Number LocalPhoneNumber	478-1410
	dei	Security12b Title Security12bTitle	None
	dei	Trading Symbol TradingSymbol	N/A
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	146172439	shares
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	423060	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1351364	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1070358	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3000000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2608490	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1383369	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8678	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	5485276	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4360042	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	436508	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11399	usd
CY2023Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	1953127	usd
CY2023Q2	ssii	Loans Advances Related Party LoansAdvancesRelatedParty	1818420	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	4208054	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11399	usd
CY2023Q2	us-gaap	Assets Assets	9693331	usd
CY2022Q4	us-gaap	Assets Assets	4371441	usd
CY2023Q2	us-gaap	Bank Overdrafts BankOverdrafts	4963385	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1225000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4000000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	31760	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	20760	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2130831	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8371736	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4051229	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	500000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	8871736	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4051229	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	ssii	Common Stock Share Issued CommonStockShareIssued	146172432	shares
CY2023Q2	ssii	Common Stock Share Outstanding CommonStockShareOutstanding	146172432	shares
CY2022Q4	ssii	Common Stock Share Issued CommonStockShareIssued	53892748	shares
CY2022Q4	ssii	Common Stock Share Outstanding CommonStockShareOutstanding	53892748	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	14615	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5389	usd
CY2023Q2	ssii	Translation Adjustment TranslationAdjustment	-157646	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19166730	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11005895	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	899917	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19102022	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10691071	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	821595	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	320213	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9693331	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4371441	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1351143	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	224164	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1983053	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	170030	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1983053	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	170031	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1758890	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-170031	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-91533	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-29	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-91533	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1850423	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	170002	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1850423	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-170002	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	133791407	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37886780	shares
	us-gaap	Cost Of Revenue CostOfRevenue	2351347	usd
	us-gaap	Gross Profit GrossProfit	735339	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3400013	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	250486	usd
	us-gaap	Operating Expenses OperatingExpenses	3400013	usd
	us-gaap	Operating Expenses OperatingExpenses	250486	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2664674	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-250486	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-173791	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	64	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-173791	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	64	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2838465	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	250422	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2838465	usd
	us-gaap	Net Income Loss NetIncomeLoss	-250422	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	98172406	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	37867989	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	320213	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1597693	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	432672	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1155.56	usd
CY2023Q1	ssii	Net Loss NetLoss	-2004320	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	347414	usd
CY2023Q2	ssii	Recapitalization Recapitalization	0	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6138541	usd
CY2023Q2	ssii	Recapitalization One RecapitalizationOne	-4556208	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	742271	usd
CY2023Q2	ssii	Net Loss NetLoss	-1850423	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	821595	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	141326	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27476	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	764	usd
CY2022Q1	ssii	Net Loss NetLoss	-80421	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	89145	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25189	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	72081	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	41337	usd
CY2022Q2	ssii	Net Loss NetLoss	-170002	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	57751	usd
	us-gaap	Profit Loss ProfitLoss	-2838465	usd
	us-gaap	Profit Loss ProfitLoss	-250422	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	310897	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4586	usd
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	157645	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10626023	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	94766	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2632123	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-65696	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10679114	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-216766	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	736006	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	3771547	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1507552	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4963385	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	8170061	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	72081	usd
	ssii	Accumulated Other Comprehensive Incomeloss AccumulatedOtherComprehensiveIncomeloss	899917	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2775000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11258363	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	72081	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-928304	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-144685	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1351364	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	405774	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423060	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	261089	usd
	ssii	Working Capital Deficit WorkingCapitalDeficit	2886460	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19102022	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1850423	usd
	ssii	Aggregate Amounts AggregateAmounts	20000000	usd
	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.74
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1225000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses. The Company regularly evaluates estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates made by management.</span></p>
CY2023Q2	ssii	Closing Rate ClosingRate	82.0735
CY2023Q2	ssii	Average Rate AverageRate	82.0962
CY2023Q2	us-gaap	Inventory Net InventoryNet	2608490	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Concentration of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its principal cash balance in United States financial institutions, where deposits are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company also maintains cash balances maintained with banks in India, where balances are insured by Deposit Insurance and Credit Guarantee Corporation of India (DICGC) to the extent of approximately US$ 6,100 per account and in the Bahamas, where deposits are insured by the Deposit Insurance Corporation of Bahamas insures deposits up to US$50,000 per account. As at June 30,2023, $ 63,755 of deposits were in excess of overall insurance coverage limits.</span></p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	6100	usd
CY2023Q2	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	50000	usd
	us-gaap	Payments For Deposits PaymentsForDeposits	63755	usd
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	936262	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2162591	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	51229	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	870719	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	434212	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	436508	usd
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	310897	usd
	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	4585	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	1070358	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1070358	usd
CY2023Q2	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1953127	usd
CY2023Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	1953127	usd
	ssii	Deferred Payment Terms DeferredPaymentTerms	1953127	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	31760	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2130831	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-12-31
CY2023Q2	ssii	Aggregate Amount AggregateAmount	20000000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.74
	us-gaap	Assets Average Outstanding AssetsAverageOutstanding	1225000	usd
CY2023Q2	us-gaap	Bank Overdrafts BankOverdrafts	4963385	usd
CY2023Q2	us-gaap	Deposit Assets DepositAssets	4265529	usd
CY2023Q2	us-gaap	Deposits Deposits	41426	usd
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	135808884	shares
	ssii	Common Stock Ownership Percentage CommonStockOwnershipPercentage	0.95	pure
	ssii	Exercise Percentage exercisePercentage	0.51	pure
CY2023Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	250000000	shares
	ssii	Merger Agreement Description MergerAgreementDescription	the Company issued 14,029,170 post-Merger shares of SSII common stock to Dr. Frederic Moll and one other accredited investor, who each provided $3,000,000 in interim financing to the Company pending consummation of the Merger. Pursuant to his investment agreement with the Company, dated April 7, 2023, which included his $3,000,000 investment, and which was described in and included as an Exhibit to the Company’s Report on Form 8-K, dated April 14, 2023, Dr. Moll received 7% of SSI’s post-merger issued and outstanding common stock on a fully diluted basis or an aggregate of 10,149,232 SSI Shares
	ssii	Royalty Percentage RoyaltyPercentage	0.03	pure
CY2023Q2	us-gaap	Capital Units Total Cost To Investors CapitalUnitsTotalCostToInvestors	3000000	usd
	ssii	Lease Expiration Date LeaseExpirationDate	July 31, 2019
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1829.25	usd
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	2454.75	usd
CY2019Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2223	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	1474.17	usd
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	404.68	usd
CY2023Q2	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	194	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	16528	usd
CY2021Q1	ssii	Lease Expiration Date LeaseExpirationDate	March 2030
	ssii	Payment Plus Taxes PaymentPlusTaxes	8038	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	1818420	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	0	usd
CY2023Q2	us-gaap	Loans Payable LoansPayable	1818420	usd
CY2023Q2	us-gaap	Related Party Transaction Date RelatedPartyTransactionDate	2023-12-31
CY2023Q2	ssii	Aggregate Amount AggregateAmount	20000000	usd
	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.74
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1225000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	ssii	Translation Adjustment TranslationAdjustment		usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q2	us-gaap	Gross Profit GrossProfit		usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q1	ssii	Stock Issued During Period Security Offerings StockIssuedDuringPeriodSecurityOfferings		usd
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment		usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2022Q4	us-gaap	Bank Overdrafts BankOverdrafts		usd
CY2022Q4	us-gaap	Loans Payable LoansPayable		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001676163

Files In Submission

Name	View Source	Status
0001213900-23-064089-index-headers.html	Edgar Link	pending
0001213900-23-064089-index.html	Edgar Link	pending
0001213900-23-064089.txt	Edgar Link	pending
0001213900-23-064089-xbrl.zip	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
f10q0623ex10-1_ssinnova.htm	Edgar Link	pending
f10q0623ex10-2_ssinnova.htm	Edgar Link	pending
f10q0623ex31-1_ssinnova.htm	Edgar Link	pending
f10q0623ex31-2_ssinnova.htm	Edgar Link	pending
f10q0623ex32-1_ssinnova.htm	Edgar Link	pending
f10q0623ex32-2_ssinnova.htm	Edgar Link	pending
f10q0623_ssinnovations.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
f10q0623_ssinnovations_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssii-20230630.xsd	Edgar Link	pending
ssii-20230630_def.xml	Edgar Link	unprocessable
ssii-20230630_lab.xml	Edgar Link	unprocessable
ssii-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ssii-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSII
SS Innovations International, Inc. Stock $ssii

2023 Q3 Form 10-Q Financial Statement

#000121390023064089 Filed on August 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII SS Innovations International, Inc. Stock $ssii

2023 Q3 Form 10-Q Financial Statement

#000121390023064089 Filed on August 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSII
SS Innovations International, Inc. Stock $ssii